Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-050225

Chief Medical Officer sold 4,167 shares at $40.00 ($166,680)

  • Chief Medical Officer acquired 4,167 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BALDO LANCE · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-10 Exercise or conversion : show line 1 in the form +18 $7.80 $140 18 D
2020-09-10 Sale : show line 2 in the form −18 $40.00 $720 0 D
2020-09-11 Exercise or conversion : show line 3 in the form +4,149 $7.80 $32,362 4,149 D
2020-09-11 Sale : show line 4 in the form −4,149 $40.00 $165,960 0 D
Open-market sales · 4,167 sh · avg $40.00 · $166,680

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-09-10 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −18 429,149 D
2020-09-11 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −4,149 425,000 D
Loading xslF345X03/doc4.xml…